跳至主要内容
临床试验/IRCT20180119038433N3
IRCT20180119038433N3尚未招募3 期

Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy, a randomization clinical trial.

Semnan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Having satisfaction
  • Age over 18 years
  • Chemotherapy in Omid ward of Kowsar hospital
  • History of at least 1 course of chemotherapy
  • Use myelosuppression chemotherapy drugs
  • Lack of allergy to pegfilrastim and filgrastim
  • Absence of underlying diseases

排除标准

  • Patients with underlying disease
  • Allergy to pegfilgrastim or filgrastim
  • Severe fever and neutropenia in previous courses of chemotherapy
  • Patients with advanced cancer
  • Not consent to participate in the study

研究者

发起方
Semnan University of Medical Sciences

相似试验